Entrectinib Generates Favorable Outcomes in NTRK Fusion+ Breast Cancer
Oncology Nursing News,
Patients with breast cancer that harbors NTRK fusions achieved deep and durable responses following treatment with entrectinib (R…
Patients with breast cancer that harbors NTRK fusions achieved deep and durable responses following treatment with entrectinib (R…
Entrectinib produced deep and durable responses in patients with breast cancer harboring NTRK fusions.